1. Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers

   • Lindsey M. R. Cass
   • Constantin Efthymiopoulos
   • Alan Bye

   Original Research Article 25 November 2012 Pages: 1 - 11

2. Effect of Renal Impairment on the Pharmacokinetics of Intravenous Zanamivir

   • Lindsey M. R. Cass
   • Constantin Efthymiopoulos
   • Alan Bye

   Original Research Article 25 November 2012 Pages: 13 - 19

3. Pharmacoscintigraphic Evaluation of Lung Deposition of Inhaled Zanamivir in Healthy Volunteers

   • Lindsey M. R. Cass
   • Joanne Brown
   • Alan Bye

   Original Research Article 25 November 2012 Pages: 21 - 31

4. Deposition and Disposition of [¹¹C]Zanamivir Following Administration as an Intranasal Spray

   • Mats Bergstrom
   • Lindsey M. R. Cass
   • Bengt Langstrom

   Original Research Article 25 November 2012 Pages: 33 - 39

5. The Low Potential for Drug Interactions with Zanamivir

   • Mick J. Daniel
   • Jacqueline M. Barnett
   • Bridget A. Pearson

   Original Research Article 25 November 2012 Pages: 41 - 50

6. Coadministration of Orally Inhaled Zanamivir with Inactivated Trivalent Influenza Vaccine Does Not Adversely Affect the Production of Antihaemagglutinin Antibodies in the Serum of Healthy Volunteers

   • Alison Webster
   • Malcolm Boyce
   • Irene Miller

   Original Research Article 25 November 2012 Pages: 51 - 58